New surgical technique aims to reduce leftover cancer cells in pancreatic cancer surgery
NCT ID NCT04902352
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a specific surgical technique (called peri-adventitial dissection) can help surgeons remove all cancer cells during pancreatic cancer surgery. The trial involves 102 adults with non-spreading pancreatic tumors who are having a standard operation called a pancreaticoduodenectomy. The main goal is to see if this technique lowers the chance of cancer cells being left behind at the surgical margin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospitals Birmingham NHS Foundation Trust
Birmingham, County (Optional), B15 2GW, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill rouse the immune system against pancreatic cancer?
- A sound wave that could expose hidden pancreatic cancer?
- Can a Two-Target antibody shrink Hard-to-Treat cancers?
- Targeted chemotherapy pump takes fight directly to pancreatic cancer liver tumors
- Light-Activated therapy targets pancreatic tumors during surgery
- Engineered immune cells take aim at Mesothelin-Positive tumors